Noon J P, Walker B R, Hand M F, Webb D J
Department of Medicine, University of Edinburgh, Western General Hospital, UK.
Br J Clin Pharmacol. 1998 Jun;45(6):545-50. doi: 10.1046/j.1365-2125.1998.00718.x.
Impaired function of the vascular endothelium has been well documented in hypertension and hypercholesterolaemia. However, the 'gold standard' method for assessing endothelial function, using intra-arterial drug infusion, is invasive and has only been applied in the forearm and coronary circulations in vivo. The aim of the present study was to establish the non-invasive technique of transdermal drug iontophoresis to assess endothelial function in human dermal vessels in vivo.
In healthy male volunteers, we delivered acetylcholine (ACh) and sodium nitroprusside (SNP) to dermal vessels of the forearm using iontophoresis, and measured vasodilatation using laser Doppler fluximetry. Drugs were diluted in a methylcellulose gel vehicle which did not induce vasodilatation. To assess the contribution of nitric oxide and vasoactive prostanoids to cholinergic dilatation, the procedure was repeated during brachial artery infusion of the nitric oxide synthase inhibitor, L-N(G)-monomethyl-arginine (L-NMMA) and after intravenous administration of the cyclooxygenase inhibitor, aspirin. As a control for the vasoconstrictor effect of L-NMMA, which was measured by venous occlusion plethysmography, iontophoresis was repeated during brachial artery infusion of noradrenaline.
Flux increased in response to iontophoresis of ACh (from 45 +/- 9 to 499 +/- 80 units; P < 0.0001) and SNP (from 32 +/- 11 to 607 +/- 82 units; P < 0.0001). Brachial artery infusions of L-NMMA or noradrenaline caused reductions in forearm blood flow (by 43 +/- 2% and 44 +/- 2%, respectively) but did not inhibit vasodilatation in response to iontophoresis of ACh or SNP. In contrast, aspirin inhibited the response to iontophoresis of ACh (from 473 +/- 81 to 222 +/- 43 units; P < 0.0001) but did not affect the response to SNP (from 348 +/- 59 to 355 +/- 58).
We conclude that in healthy subjects, in contrast to the forearm circulation, dermal vasodilatation in response to iontophoresis of ACh is mediated predominately by a dilator prostanoid rather than by nitric oxide generation. Furthermore, the non-invasive technique of iontophoresis could complement existing invasive tests of endothelial function in future clinical studies.
血管内皮功能受损在高血压和高胆固醇血症中已有充分记载。然而,评估内皮功能的“金标准”方法——动脉内药物输注具有侵入性,且仅在体内的前臂和冠状动脉循环中应用过。本研究的目的是建立经皮药物离子导入的非侵入性技术,以评估人体真皮血管的内皮功能。
在健康男性志愿者中,我们使用离子导入法将乙酰胆碱(ACh)和硝普钠(SNP)输送至前臂的真皮血管,并使用激光多普勒血流仪测量血管舒张情况。药物在不会引起血管舒张的甲基纤维素凝胶载体中稀释。为评估一氧化氮和血管活性前列腺素对胆碱能舒张的作用,在肱动脉输注一氧化氮合酶抑制剂L-N(G)-单甲基精氨酸(L-NMMA)期间以及静脉注射环氧化酶抑制剂阿司匹林后重复该操作。作为通过静脉阻断体积描记法测量的L-NMMA血管收缩作用的对照,在肱动脉输注去甲肾上腺素期间重复离子导入操作。
ACh离子导入(从45±9增至499±80单位;P<0.0001)和SNP离子导入(从32±11增至607±82单位;P<0.00" role="presentation">0001)后通量增加。肱动脉输注L-NMMA或去甲肾上腺素导致前臂血流量减少(分别减少43±2%和44±2%),但不抑制对ACh或SNP离子导入的血管舒张反应。相比之下,阿司匹林抑制对ACh离子导入的反应(从473±81降至222±43单位;P<0.0001),但不影响对SNP的反应(从348±59增至355±58)。
我们得出结论,在健康受试者中,与前臂循环不同,对ACh离子导入的真皮血管舒张主要由扩张性前列腺素介导,而非一氧化氮生成。此外,离子导入的非侵入性技术在未来临床研究中可补充现有的内皮功能侵入性检测。